nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemfibrozil—SLCO1B1—Sulfasalazine—ankylosing spondylitis	0.276	0.319	CbGbCtD
Gemfibrozil—SLCO1B1—Methotrexate—ankylosing spondylitis	0.111	0.128	CbGbCtD
Gemfibrozil—CYP2C19—Prednisone—ankylosing spondylitis	0.0785	0.0906	CbGbCtD
Gemfibrozil—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0626	0.0723	CbGbCtD
Gemfibrozil—CYP2C8—Dexamethasone—ankylosing spondylitis	0.0584	0.0674	CbGbCtD
Gemfibrozil—CYP2C19—Dexamethasone—ankylosing spondylitis	0.049	0.0565	CbGbCtD
Gemfibrozil—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0474	0.0548	CbGbCtD
Gemfibrozil—CYP2C9—Dexamethasone—ankylosing spondylitis	0.0407	0.047	CbGbCtD
Gemfibrozil—CYP3A4—Betamethasone—ankylosing spondylitis	0.0407	0.047	CbGbCtD
Gemfibrozil—CYP3A4—Prednisolone—ankylosing spondylitis	0.0402	0.0464	CbGbCtD
Gemfibrozil—CYP3A4—Prednisone—ankylosing spondylitis	0.0379	0.0438	CbGbCtD
Gemfibrozil—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0237	0.0273	CbGbCtD
Gemfibrozil—Pancreatitis—Triamcinolone—ankylosing spondylitis	0.000734	0.0055	CcSEcCtD
Gemfibrozil—Pancreatitis—Methylprednisolone—ankylosing spondylitis	0.000732	0.00548	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Prednisolone—ankylosing spondylitis	0.000711	0.00533	CcSEcCtD
Gemfibrozil—Muscular weakness—Dexamethasone—ankylosing spondylitis	0.000693	0.00519	CcSEcCtD
Gemfibrozil—Muscular weakness—Betamethasone—ankylosing spondylitis	0.000693	0.00519	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Triamcinolone—ankylosing spondylitis	0.000654	0.0049	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Methylprednisolone—ankylosing spondylitis	0.000653	0.00489	CcSEcCtD
Gemfibrozil—Photosensitivity—Methotrexate—ankylosing spondylitis	0.000651	0.00488	CcSEcCtD
Gemfibrozil—Weight decreased—Betamethasone—ankylosing spondylitis	0.000614	0.0046	CcSEcCtD
Gemfibrozil—Weight decreased—Dexamethasone—ankylosing spondylitis	0.000614	0.0046	CcSEcCtD
Gemfibrozil—Dermatitis exfoliative—Methotrexate—ankylosing spondylitis	0.000606	0.00454	CcSEcCtD
Gemfibrozil—Muscular weakness—Prednisone—ankylosing spondylitis	0.000604	0.00452	CcSEcCtD
Gemfibrozil—Rhinitis—Triamcinolone—ankylosing spondylitis	0.000601	0.0045	CcSEcCtD
Gemfibrozil—Rhinitis—Methylprednisolone—ankylosing spondylitis	0.000599	0.00449	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Dexamethasone—ankylosing spondylitis	0.000594	0.00445	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Betamethasone—ankylosing spondylitis	0.000594	0.00445	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.000587	0.0044	CcSEcCtD
Gemfibrozil—Pancreatitis—Prednisone—ankylosing spondylitis	0.00058	0.00434	CcSEcCtD
Gemfibrozil—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.000559	0.00418	CcSEcCtD
Gemfibrozil—Erectile dysfunction—Prednisone—ankylosing spondylitis	0.000545	0.00408	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.000539	0.00403	CcSEcCtD
Gemfibrozil—Weight decreased—Prednisone—ankylosing spondylitis	0.000535	0.00401	CcSEcCtD
Gemfibrozil—Vision blurred—Prednisolone—ankylosing spondylitis	0.000534	0.004	CcSEcCtD
Gemfibrozil—Liver function test abnormal—Methotrexate—ankylosing spondylitis	0.000528	0.00395	CcSEcCtD
Gemfibrozil—Depression—Prednisone—ankylosing spondylitis	0.000526	0.00394	CcSEcCtD
Gemfibrozil—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.000524	0.00392	CcSEcCtD
Gemfibrozil—Angioedema—Prednisolone—ankylosing spondylitis	0.000518	0.00388	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Prednisone—ankylosing spondylitis	0.000517	0.00387	CcSEcCtD
Gemfibrozil—Breast disorder—Methotrexate—ankylosing spondylitis	0.000517	0.00387	CcSEcCtD
Gemfibrozil—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.000511	0.00382	CcSEcCtD
Gemfibrozil—Vertigo—Prednisolone—ankylosing spondylitis	0.00051	0.00382	CcSEcCtD
Gemfibrozil—Syncope—Prednisolone—ankylosing spondylitis	0.000509	0.00381	CcSEcCtD
Gemfibrozil—Eye disorder—Betamethasone—ankylosing spondylitis	0.000508	0.0038	CcSEcCtD
Gemfibrozil—Eye disorder—Dexamethasone—ankylosing spondylitis	0.000508	0.0038	CcSEcCtD
Gemfibrozil—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.000498	0.00373	CcSEcCtD
Gemfibrozil—Convulsion—Prednisolone—ankylosing spondylitis	0.000491	0.00368	CcSEcCtD
Gemfibrozil—Eosinophilia—Methotrexate—ankylosing spondylitis	0.000489	0.00367	CcSEcCtD
Gemfibrozil—Pancreatitis—Methotrexate—ankylosing spondylitis	0.000485	0.00363	CcSEcCtD
Gemfibrozil—Alopecia—Dexamethasone—ankylosing spondylitis	0.00048	0.0036	CcSEcCtD
Gemfibrozil—Alopecia—Betamethasone—ankylosing spondylitis	0.00048	0.0036	CcSEcCtD
Gemfibrozil—Angioedema—Triamcinolone—ankylosing spondylitis	0.000477	0.00357	CcSEcCtD
Gemfibrozil—Angioedema—Methylprednisolone—ankylosing spondylitis	0.000475	0.00356	CcSEcCtD
Gemfibrozil—Pancytopenia—Methotrexate—ankylosing spondylitis	0.000469	0.00352	CcSEcCtD
Gemfibrozil—Vertigo—Triamcinolone—ankylosing spondylitis	0.000469	0.00351	CcSEcCtD
Gemfibrozil—Syncope—Triamcinolone—ankylosing spondylitis	0.000468	0.0035	CcSEcCtD
Gemfibrozil—Vertigo—Methylprednisolone—ankylosing spondylitis	0.000468	0.0035	CcSEcCtD
Gemfibrozil—Syncope—Methylprednisolone—ankylosing spondylitis	0.000467	0.00349	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.000465	0.00348	CcSEcCtD
Gemfibrozil—Oedema—Prednisolone—ankylosing spondylitis	0.000463	0.00347	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000463	0.00347	CcSEcCtD
Gemfibrozil—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000458	0.00343	CcSEcCtD
Gemfibrozil—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.000457	0.00343	CcSEcCtD
Gemfibrozil—Shock—Prednisolone—ankylosing spondylitis	0.000455	0.00341	CcSEcCtD
Gemfibrozil—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.000455	0.00341	CcSEcCtD
Gemfibrozil—Cough—Triamcinolone—ankylosing spondylitis	0.000455	0.00341	CcSEcCtD
Gemfibrozil—Convulsion—Triamcinolone—ankylosing spondylitis	0.000452	0.00338	CcSEcCtD
Gemfibrozil—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.000451	0.00338	CcSEcCtD
Gemfibrozil—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000451	0.00338	CcSEcCtD
Gemfibrozil—Myalgia—Triamcinolone—ankylosing spondylitis	0.000444	0.00333	CcSEcCtD
Gemfibrozil—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000443	0.00332	CcSEcCtD
Gemfibrozil—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000443	0.00332	CcSEcCtD
Gemfibrozil—Eye disorder—Prednisone—ankylosing spondylitis	0.000442	0.00331	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00044	0.0033	CcSEcCtD
Gemfibrozil—Depression—Methotrexate—ankylosing spondylitis	0.000439	0.00329	CcSEcCtD
Gemfibrozil—Renal failure—Methotrexate—ankylosing spondylitis	0.000433	0.00324	CcSEcCtD
Gemfibrozil—Angioedema—Betamethasone—ankylosing spondylitis	0.000432	0.00324	CcSEcCtD
Gemfibrozil—Angioedema—Dexamethasone—ankylosing spondylitis	0.000432	0.00324	CcSEcCtD
Gemfibrozil—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000428	0.00321	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000426	0.00319	CcSEcCtD
Gemfibrozil—Oedema—Triamcinolone—ankylosing spondylitis	0.000426	0.00319	CcSEcCtD
Gemfibrozil—Vertigo—Betamethasone—ankylosing spondylitis	0.000425	0.00318	CcSEcCtD
Gemfibrozil—Vertigo—Dexamethasone—ankylosing spondylitis	0.000425	0.00318	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000425	0.00318	CcSEcCtD
Gemfibrozil—Syncope—Betamethasone—ankylosing spondylitis	0.000424	0.00318	CcSEcCtD
Gemfibrozil—Syncope—Dexamethasone—ankylosing spondylitis	0.000424	0.00318	CcSEcCtD
Gemfibrozil—Shock—Triamcinolone—ankylosing spondylitis	0.000419	0.00314	CcSEcCtD
Gemfibrozil—Alopecia—Prednisone—ankylosing spondylitis	0.000418	0.00313	CcSEcCtD
Gemfibrozil—Shock—Methylprednisolone—ankylosing spondylitis	0.000418	0.00313	CcSEcCtD
Gemfibrozil—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000417	0.00312	CcSEcCtD
Gemfibrozil—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000416	0.00312	CcSEcCtD
Gemfibrozil—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000416	0.00311	CcSEcCtD
Gemfibrozil—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000416	0.00311	CcSEcCtD
Gemfibrozil—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000416	0.00311	CcSEcCtD
Gemfibrozil—Mental disorder—Prednisone—ankylosing spondylitis	0.000415	0.00311	CcSEcCtD
Gemfibrozil—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000413	0.00309	CcSEcCtD
Gemfibrozil—Convulsion—Dexamethasone—ankylosing spondylitis	0.00041	0.00307	CcSEcCtD
Gemfibrozil—Convulsion—Betamethasone—ankylosing spondylitis	0.00041	0.00307	CcSEcCtD
Gemfibrozil—Myalgia—Betamethasone—ankylosing spondylitis	0.000403	0.00302	CcSEcCtD
Gemfibrozil—Myalgia—Dexamethasone—ankylosing spondylitis	0.000403	0.00302	CcSEcCtD
Gemfibrozil—Pain—Prednisolone—ankylosing spondylitis	0.000396	0.00296	CcSEcCtD
Gemfibrozil—Vision blurred—Prednisone—ankylosing spondylitis	0.000388	0.00291	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000388	0.0029	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000387	0.0029	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000386	0.00289	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000386	0.00289	CcSEcCtD
Gemfibrozil—Oedema—Betamethasone—ankylosing spondylitis	0.000386	0.00289	CcSEcCtD
Gemfibrozil—Oedema—Dexamethasone—ankylosing spondylitis	0.000386	0.00289	CcSEcCtD
Gemfibrozil—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000382	0.00286	CcSEcCtD
Gemfibrozil—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000381	0.00286	CcSEcCtD
Gemfibrozil—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000381	0.00286	CcSEcCtD
Gemfibrozil—Anaemia—Prednisone—ankylosing spondylitis	0.000381	0.00285	CcSEcCtD
Gemfibrozil—Shock—Dexamethasone—ankylosing spondylitis	0.00038	0.00285	CcSEcCtD
Gemfibrozil—Shock—Betamethasone—ankylosing spondylitis	0.00038	0.00285	CcSEcCtD
Gemfibrozil—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000379	0.00284	CcSEcCtD
Gemfibrozil—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000379	0.00284	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000378	0.00283	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000378	0.00283	CcSEcCtD
Gemfibrozil—Angioedema—Prednisone—ankylosing spondylitis	0.000377	0.00282	CcSEcCtD
Gemfibrozil—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000375	0.00281	CcSEcCtD
Gemfibrozil—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000374	0.0028	CcSEcCtD
Gemfibrozil—Vertigo—Prednisone—ankylosing spondylitis	0.00037	0.00277	CcSEcCtD
Gemfibrozil—Eye disorder—Methotrexate—ankylosing spondylitis	0.00037	0.00277	CcSEcCtD
Gemfibrozil—Syncope—Prednisone—ankylosing spondylitis	0.00037	0.00277	CcSEcCtD
Gemfibrozil—Urticaria—Prednisolone—ankylosing spondylitis	0.000368	0.00275	CcSEcCtD
Gemfibrozil—Fatigue—Triamcinolone—ankylosing spondylitis	0.000367	0.00275	CcSEcCtD
Gemfibrozil—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000366	0.00274	CcSEcCtD
Gemfibrozil—Pain—Triamcinolone—ankylosing spondylitis	0.000364	0.00273	CcSEcCtD
Gemfibrozil—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000362	0.00271	CcSEcCtD
Gemfibrozil—Convulsion—Prednisone—ankylosing spondylitis	0.000357	0.00267	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000357	0.00267	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000352	0.00264	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000352	0.00264	CcSEcCtD
Gemfibrozil—Arthralgia—Prednisone—ankylosing spondylitis	0.000351	0.00263	CcSEcCtD
Gemfibrozil—Myalgia—Prednisone—ankylosing spondylitis	0.000351	0.00263	CcSEcCtD
Gemfibrozil—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000351	0.00263	CcSEcCtD
Gemfibrozil—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00035	0.00262	CcSEcCtD
Gemfibrozil—Alopecia—Methotrexate—ankylosing spondylitis	0.00035	0.00262	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000348	0.00261	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000347	0.0026	CcSEcCtD
Gemfibrozil—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000347	0.0026	CcSEcCtD
Gemfibrozil—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000347	0.0026	CcSEcCtD
Gemfibrozil—Mental disorder—Methotrexate—ankylosing spondylitis	0.000347	0.0026	CcSEcCtD
Gemfibrozil—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00034	0.00255	CcSEcCtD
Gemfibrozil—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00034	0.00255	CcSEcCtD
Gemfibrozil—Urticaria—Triamcinolone—ankylosing spondylitis	0.000338	0.00253	CcSEcCtD
Gemfibrozil—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000337	0.00253	CcSEcCtD
Gemfibrozil—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000337	0.00253	CcSEcCtD
Gemfibrozil—Oedema—Prednisone—ankylosing spondylitis	0.000336	0.00252	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000336	0.00252	CcSEcCtD
Gemfibrozil—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000336	0.00251	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000333	0.0025	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000333	0.0025	CcSEcCtD
Gemfibrozil—Fatigue—Betamethasone—ankylosing spondylitis	0.000333	0.00249	CcSEcCtD
Gemfibrozil—Fatigue—Dexamethasone—ankylosing spondylitis	0.000333	0.00249	CcSEcCtD
Gemfibrozil—Shock—Prednisone—ankylosing spondylitis	0.000331	0.00248	CcSEcCtD
Gemfibrozil—Pain—Dexamethasone—ankylosing spondylitis	0.00033	0.00247	CcSEcCtD
Gemfibrozil—Pain—Betamethasone—ankylosing spondylitis	0.00033	0.00247	CcSEcCtD
Gemfibrozil—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00033	0.00247	CcSEcCtD
Gemfibrozil—Skin disorder—Prednisone—ankylosing spondylitis	0.000327	0.00245	CcSEcCtD
Gemfibrozil—Vision blurred—Methotrexate—ankylosing spondylitis	0.000325	0.00243	CcSEcCtD
Gemfibrozil—Anaemia—Methotrexate—ankylosing spondylitis	0.000318	0.00238	CcSEcCtD
Gemfibrozil—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000318	0.00238	CcSEcCtD
Gemfibrozil—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000318	0.00238	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000316	0.00237	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000316	0.00237	CcSEcCtD
Gemfibrozil—Vertigo—Methotrexate—ankylosing spondylitis	0.000309	0.00232	CcSEcCtD
Gemfibrozil—Leukopenia—Methotrexate—ankylosing spondylitis	0.000308	0.00231	CcSEcCtD
Gemfibrozil—Urticaria—Betamethasone—ankylosing spondylitis	0.000307	0.0023	CcSEcCtD
Gemfibrozil—Urticaria—Dexamethasone—ankylosing spondylitis	0.000307	0.0023	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000306	0.00229	CcSEcCtD
Gemfibrozil—Dizziness—Prednisolone—ankylosing spondylitis	0.000306	0.00229	CcSEcCtD
Gemfibrozil—Asthenia—Triamcinolone—ankylosing spondylitis	0.000305	0.00229	CcSEcCtD
Gemfibrozil—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000305	0.00229	CcSEcCtD
Gemfibrozil—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000305	0.00229	CcSEcCtD
Gemfibrozil—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000305	0.00228	CcSEcCtD
Gemfibrozil—Paraesthesia—Prednisone—ankylosing spondylitis	0.000302	0.00226	CcSEcCtD
Gemfibrozil—Pruritus—Triamcinolone—ankylosing spondylitis	0.000301	0.00226	CcSEcCtD
Gemfibrozil—Cough—Methotrexate—ankylosing spondylitis	0.000301	0.00225	CcSEcCtD
Gemfibrozil—Pruritus—Methylprednisolone—ankylosing spondylitis	0.0003	0.00225	CcSEcCtD
Gemfibrozil—Convulsion—Methotrexate—ankylosing spondylitis	0.000298	0.00223	CcSEcCtD
Gemfibrozil—Dyspepsia—Prednisone—ankylosing spondylitis	0.000296	0.00222	CcSEcCtD
Gemfibrozil—Chest pain—Methotrexate—ankylosing spondylitis	0.000293	0.0022	CcSEcCtD
Gemfibrozil—Arthralgia—Methotrexate—ankylosing spondylitis	0.000293	0.0022	CcSEcCtD
Gemfibrozil—Myalgia—Methotrexate—ankylosing spondylitis	0.000293	0.0022	CcSEcCtD
Gemfibrozil—Rash—Prednisolone—ankylosing spondylitis	0.000292	0.00219	CcSEcCtD
Gemfibrozil—Dermatitis—Prednisolone—ankylosing spondylitis	0.000292	0.00218	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000291	0.00218	CcSEcCtD
Gemfibrozil—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000291	0.00218	CcSEcCtD
Gemfibrozil—Fatigue—Prednisone—ankylosing spondylitis	0.00029	0.00217	CcSEcCtD
Gemfibrozil—Headache—Prednisolone—ankylosing spondylitis	0.00029	0.00217	CcSEcCtD
Gemfibrozil—Constipation—Prednisone—ankylosing spondylitis	0.000288	0.00215	CcSEcCtD
Gemfibrozil—Confusional state—Methotrexate—ankylosing spondylitis	0.000283	0.00212	CcSEcCtD
Gemfibrozil—Dizziness—Triamcinolone—ankylosing spondylitis	0.000281	0.00211	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000281	0.00211	CcSEcCtD
Gemfibrozil—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000281	0.0021	CcSEcCtD
Gemfibrozil—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000277	0.00208	CcSEcCtD
Gemfibrozil—Asthenia—Dexamethasone—ankylosing spondylitis	0.000277	0.00208	CcSEcCtD
Gemfibrozil—Asthenia—Betamethasone—ankylosing spondylitis	0.000277	0.00208	CcSEcCtD
Gemfibrozil—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000276	0.00206	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000275	0.00206	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000275	0.00206	CcSEcCtD
Gemfibrozil—Nausea—Prednisolone—ankylosing spondylitis	0.000275	0.00206	CcSEcCtD
Gemfibrozil—Pruritus—Dexamethasone—ankylosing spondylitis	0.000273	0.00205	CcSEcCtD
Gemfibrozil—Pruritus—Betamethasone—ankylosing spondylitis	0.000273	0.00205	CcSEcCtD
Gemfibrozil—Skin disorder—Methotrexate—ankylosing spondylitis	0.000273	0.00204	CcSEcCtD
Gemfibrozil—Vomiting—Triamcinolone—ankylosing spondylitis	0.000271	0.00203	CcSEcCtD
Gemfibrozil—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00027	0.00202	CcSEcCtD
Gemfibrozil—Rash—Triamcinolone—ankylosing spondylitis	0.000268	0.00201	CcSEcCtD
Gemfibrozil—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000268	0.00201	CcSEcCtD
Gemfibrozil—Rash—Methylprednisolone—ankylosing spondylitis	0.000268	0.00201	CcSEcCtD
Gemfibrozil—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000268	0.002	CcSEcCtD
Gemfibrozil—Urticaria—Prednisone—ankylosing spondylitis	0.000267	0.002	CcSEcCtD
Gemfibrozil—Headache—Triamcinolone—ankylosing spondylitis	0.000267	0.002	CcSEcCtD
Gemfibrozil—Headache—Methylprednisolone—ankylosing spondylitis	0.000266	0.00199	CcSEcCtD
Gemfibrozil—Abdominal pain—Prednisone—ankylosing spondylitis	0.000266	0.00199	CcSEcCtD
Gemfibrozil—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000264	0.00198	CcSEcCtD
Gemfibrozil—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000264	0.00198	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000256	0.00192	CcSEcCtD
Gemfibrozil—Dizziness—Dexamethasone—ankylosing spondylitis	0.000255	0.00191	CcSEcCtD
Gemfibrozil—Dizziness—Betamethasone—ankylosing spondylitis	0.000255	0.00191	CcSEcCtD
Gemfibrozil—Nausea—Triamcinolone—ankylosing spondylitis	0.000253	0.00189	CcSEcCtD
Gemfibrozil—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000252	0.00189	CcSEcCtD
Gemfibrozil—Nausea—Methylprednisolone—ankylosing spondylitis	0.000252	0.00189	CcSEcCtD
Gemfibrozil—Somnolence—Methotrexate—ankylosing spondylitis	0.00025	0.00187	CcSEcCtD
Gemfibrozil—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000247	0.00185	CcSEcCtD
Gemfibrozil—Vomiting—Betamethasone—ankylosing spondylitis	0.000246	0.00184	CcSEcCtD
Gemfibrozil—Vomiting—Dexamethasone—ankylosing spondylitis	0.000246	0.00184	CcSEcCtD
Gemfibrozil—Rash—Dexamethasone—ankylosing spondylitis	0.000244	0.00182	CcSEcCtD
Gemfibrozil—Rash—Betamethasone—ankylosing spondylitis	0.000244	0.00182	CcSEcCtD
Gemfibrozil—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000243	0.00182	CcSEcCtD
Gemfibrozil—Dermatitis—Betamethasone—ankylosing spondylitis	0.000243	0.00182	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000243	0.00182	CcSEcCtD
Gemfibrozil—Fatigue—Methotrexate—ankylosing spondylitis	0.000242	0.00181	CcSEcCtD
Gemfibrozil—Headache—Betamethasone—ankylosing spondylitis	0.000242	0.00181	CcSEcCtD
Gemfibrozil—Headache—Dexamethasone—ankylosing spondylitis	0.000242	0.00181	CcSEcCtD
Gemfibrozil—Asthenia—Prednisone—ankylosing spondylitis	0.000241	0.00181	CcSEcCtD
Gemfibrozil—Pain—Methotrexate—ankylosing spondylitis	0.00024	0.0018	CcSEcCtD
Gemfibrozil—Pruritus—Prednisone—ankylosing spondylitis	0.000238	0.00178	CcSEcCtD
Gemfibrozil—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000232	0.00173	CcSEcCtD
Gemfibrozil—Diarrhoea—Prednisone—ankylosing spondylitis	0.00023	0.00172	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00023	0.00172	CcSEcCtD
Gemfibrozil—Nausea—Betamethasone—ankylosing spondylitis	0.000229	0.00172	CcSEcCtD
Gemfibrozil—Nausea—Dexamethasone—ankylosing spondylitis	0.000229	0.00172	CcSEcCtD
Gemfibrozil—Urticaria—Methotrexate—ankylosing spondylitis	0.000223	0.00167	CcSEcCtD
Gemfibrozil—Dizziness—Prednisone—ankylosing spondylitis	0.000222	0.00167	CcSEcCtD
Gemfibrozil—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000222	0.00166	CcSEcCtD
Gemfibrozil—Vomiting—Prednisone—ankylosing spondylitis	0.000214	0.0016	CcSEcCtD
Gemfibrozil—Rash—Prednisone—ankylosing spondylitis	0.000212	0.00159	CcSEcCtD
Gemfibrozil—Dermatitis—Prednisone—ankylosing spondylitis	0.000212	0.00159	CcSEcCtD
Gemfibrozil—Headache—Prednisone—ankylosing spondylitis	0.000211	0.00158	CcSEcCtD
Gemfibrozil—Asthenia—Methotrexate—ankylosing spondylitis	0.000202	0.00151	CcSEcCtD
Gemfibrozil—Nausea—Prednisone—ankylosing spondylitis	0.0002	0.0015	CcSEcCtD
Gemfibrozil—Pruritus—Methotrexate—ankylosing spondylitis	0.000199	0.00149	CcSEcCtD
Gemfibrozil—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000192	0.00144	CcSEcCtD
Gemfibrozil—Dizziness—Methotrexate—ankylosing spondylitis	0.000186	0.00139	CcSEcCtD
Gemfibrozil—Vomiting—Methotrexate—ankylosing spondylitis	0.000179	0.00134	CcSEcCtD
Gemfibrozil—Rash—Methotrexate—ankylosing spondylitis	0.000177	0.00133	CcSEcCtD
Gemfibrozil—Dermatitis—Methotrexate—ankylosing spondylitis	0.000177	0.00133	CcSEcCtD
Gemfibrozil—Headache—Methotrexate—ankylosing spondylitis	0.000176	0.00132	CcSEcCtD
Gemfibrozil—Nausea—Methotrexate—ankylosing spondylitis	0.000167	0.00125	CcSEcCtD
